-
Created market scenario and identified low-hanging opportunities in terms of products and unmet needs
-
Provided a bespoke value proposition to access scientific proof to prioritise and benchmark indications
-
Helped narrow focus on the selected high-potential indications from the opportunity canvas
CLIENT CHALLENGES
- Identify key central nervous system (CNS) indications to repurpose its asset and position a new suite of offerings to maximise product uptake and patient adherence
OUR APPROACH
- Market assessment and evaluation of CNS disorders
- Analysed disease landscape, patient journey and treatment options for different CNS disorders across geographies
- Conducted a systematic literature review and detailed analysis of pre-clinical and clinical trial landscape across multiple CNS indications
- Indication identification
- Identified and selected valuable portfolio opportunities for optimising asset offerings
- Assessed technological and feasibility challenges that needed to be addressed
- Determined regulatory hurdles and other bottlenecks related to repositioning of drugs
- Indication prioritisation
- Conducted evidence-based indication prioritisation to navigate disease segmentation landscape
- Benchmarked key indications and evaluated business opportunities in multiple indications
VALUE DELIVERED
- Identified a new patient pool for the client’s asset and created a bespoke value proposition considering scientific rationale, unmet needs, market positioning and scale of development
- Evaluated business opportunities in multiple CNS indications based on growth potential, client’s current capabilities and gaps in the portfolio
- Provided bespoke research support on key competitors and data evidence for patient adherence
![](https://www.acuitykp.com/wp-content/themes/maks/images/success-img.png)
Thank you for sharing your details
Your file will start downloading automatically
If it does not download within 1 minute,